Skip to main content
. 2022 Sep 26;2022(9):CD015048. doi: 10.1002/14651858.CD015048.pub2

Comparison 8. PDS: LVRD (> 5 cm) versus NMRD (stage IV disease).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
8.1 Overall survival 1   Hazard Ratio (IV, Random, 95% CI) Subtotals only
8.2 Progression‐free survival 1   Hazard Ratio (IV, Random, 95% CI) Subtotals only